Neuberger Berman Group
GILD icon

Neuberger Berman Group’s Gilead Sciences GILD Stock Holding History

Neuberger Berman Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,843
Closed -$1.21M – 1558
2020
Q1 		$1.21M Buy
+1,843
New +$127K ﹤0.01% 1055

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group's GILD Position: Q2 2026 in Review

Neuberger Berman Group increased its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, buying an estimated $4.05M and bringing the position to 1,361,825 shares worth $172M. The position accounts for 0.11% of the portfolio, ranked #198.

Neuberger Berman Group first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $902M in Q4 2023. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Neuberger Berman Group held 1,361,825 shares of Gilead Sciences worth $172M as of Q2 2026.
  • Neuberger Berman Group bought 30,767 Gilead Sciences shares in Q2 2026, an estimated $4.05M.
  • Gilead Sciences made up 0.11% of Neuberger Berman Group's portfolio in Q2 2026, its #198 holding.
  • Neuberger Berman Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Neuberger Berman Group's Gilead Sciences position peaked at $902M in Q4 2023.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.